United Therapeutics CFO sells 10k shares, exercises options
United Therapeutics CFO and Treasurer James Edgemond reported a combination of stock option exercises and share sales in the company’s common stock.
Rhea-AI Filing Summary
United Therapeutics CFO and Treasurer James Edgemond reported a combination of stock option exercises and share sales in the company’s common stock. On May 18, 2026, he exercised options for 10,000 shares at strike prices of $117.76 and $135.42 per share, then sold 10,000 shares in multiple open-market transactions at prices between approximately $562.91 and $570.18. The filing states these transactions were carried out under a pre-arranged Rule 10b5-1 trading plan entered into on October 31, 2025, and he continues to hold United Therapeutics common stock following the activity.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.45M approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.67M)
Approx. gross sale proceeds
$5.67M
Approx. exercise cost
$1.22M
Approx. pre-tax spread
$4.45M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 2,500 | $0.00 | $0.00 |
| Exercise | Stock Option | 7,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,500 | $135.42 | $339K |
| Exercise | Common Stock | 7,500 | $117.76 | $883K |
| Sale | Common Stock | 200 | $562.9072 | $113K |
| Sale | Common Stock | 422 | $564.3045 | $238K |
| Sale | Common Stock | 2,131 | $565.438 | $1.20M |
| Sale | Common Stock | 1,796 | $566.3863 | $1.02M |
| Sale | Common Stock | 2,785 | $568.4765 | $1.58M |
| Sale | Common Stock | 1,304 | $568.4301 | $741K |
| Sale | Common Stock | 1,322 | $569.5576 | $753K |
| Sale | Common Stock | 40 | $570.18 | $23K |
Holdings After Transaction:
Stock Option — 80,000 contracts (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (8)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $562.56 to $563.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $563.93 to $564.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $564.93 to $565.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $565.96 to $566.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $567.01 to $567.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $568.01 to $569.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $569.17 to $570.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Options exercised: 10,000 shares
Sale price range: $562.9072–$570.18 per share
+4 more
7 metrics
Shares sold
10,000 shares
Common stock sales on May 18, 2026
Options exercised
10,000 shares
Stock option exercises on May 18, 2026
Sale price range
$562.9072–$570.18 per share
Weighted-average prices for open-market sales
Option strike price 1
$117.76 per share
7,500-share stock option exercise
Option strike price 2
$135.42 per share
2,500-share stock option exercise
Sale transaction count
8 sale entries
Non-derivative open-market sales of common stock
Exercise transaction count
2 exercises
Non-derivative exercises of options into common stock
Key Terms
Rule 10b5-1 trading plan, stock option, derivative security, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock option financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did United Therapeutics (UTHR) CFO James Edgemond report in this Form 4?
He reported exercising stock options and selling common shares of United Therapeutics. On May 18, 2026, he exercised options for 10,000 shares and sold 10,000 shares in multiple open-market transactions while continuing to hold stock afterward.
How many United Therapeutics (UTHR) options did the CFO exercise, and at what strike prices?
He exercised stock options covering 10,000 shares of common stock. The filing shows 7,500 shares exercised at a strike price of $117.76 per share and 2,500 shares exercised at a strike price of $135.42 per share on May 18, 2026.
What is meant by weighted average prices in the CFO’s United Therapeutics (UTHR) trades?
Several sale entries note they were executed in multiple trades within specified price ranges. The single price reported for each entry is the weighted average price, summarizing all individual executions for disclosure, with full details available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
